Search Results - "Sedlak, Frantisek"
-
1
Designing the nanobiointerface of fluorescent nanodiamonds: highly selective targeting of glioma cancer cells
Published in Nanoscale (14-01-2015)“…Core-shell nanoparticles based on fluorescent nanodiamonds coated with a biocompatible N-(2-hydroxypropyl)methacrylamide copolymer shell were developed for…”
Get more information
Journal Article -
2
DDI2 protease controls embryonic development and inflammation via TCF11/NRF1
Published in iScience (18-10-2024)“…DDI2 is an aspartic protease that cleaves polyubiquitinated substrates. Upon proteotoxic stress, DDI2 activates the transcription factor TCF11/NRF1 (NFE2L1),…”
Get full text
Journal Article -
3
Lipid Nanoparticles for Broad‐Spectrum Nucleic Acid Delivery
Published in Advanced functional materials (01-11-2021)“…Lipid nanoparticles (LNPs) are the most advanced nonviral modality for nucleic acid (NA) delivery, and have recently gained enormous attention in the fields of…”
Get full text
Journal Article -
4
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
Published in Annals of hematology (01-06-2023)“…We performed real world evidence (RWE) analysis of daratumumab, lenalidomide and dexamethasone (Dara-Rd) versus lenalidomide and dexamethasone (Rd) treatment…”
Get full text
Journal Article -
5
Inhibitor–GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles
Published in Molecular pharmaceutics (06-08-2018)“…Glutamate carboxypeptidase II (GCPII) is a membrane protease overexpressed by prostate cancer cells and detected in the neovasculature of most solid tumors…”
Get full text
Journal Article -
6
P-159 Lenalidomide maintenance in R2-ISS stratified multiple myeloma patients - real world evidence
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)Get full text
Journal Article -
7
-
8
Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma
Published in Cancers (25-04-2020)“…Proteasome inhibitors are the backbone of multiple myeloma therapy. However, disease progression or early relapse occur due to development of resistance to the…”
Get full text
Journal Article -
9
Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition
Published in ACS chemical neuroscience (03-04-2024)“…Glutamate carboxypeptidase II (GCPII, also known as PSMA or FOLH1) is responsible for the cleavage of N-acetyl-aspartyl-glutamate (NAAG) to N-acetyl-aspartate…”
Get full text
Journal Article -
10
Human DNA-Damage-Inducible 2 Protein Is Structurally and Functionally Distinct from Its Yeast Ortholog
Published in Scientific reports (27-07-2016)“…Although Ddi1-like proteins are conserved among eukaryotes, their biological functions remain poorly characterized. Yeast Ddi1 has been implicated in cell…”
Get full text
Journal Article -
11
Urine immunofixation is not necessary for CR definition in myeloma patients with complete M protein molecule
Published in Clinical lymphoma, myeloma and leukemia (01-10-2019)Get full text
Journal Article -
12
Tuning polymer–blood and polymer–cytoplasm membrane interactions by manipulating the architecture of poly(2-oxazoline) triblock copolymers
Published in Colloids and surfaces, B, Biointerfaces (01-11-2023)“…Bioactive moieties designed to bind to cell membrane receptors benefit from coupling with polymeric carriers that have enhanced affinity to the cell membrane…”
Get full text
Journal Article -
13
Iridium‐based Polymeric Multifunctional Imaging Tools for Biochemistry
Published in ChemPlusChem (Weinheim, Germany) (01-05-2024)“…Herein, we report the development of a macromolecular multifunctional imaging tool for biological investigations, which is comprised of an…”
Get full text
Journal Article -
14
iBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties
Published in Angewandte Chemie International Edition (12-02-2016)“…Antibodies are indispensable tools for biomedicine and anticancer therapy. Nevertheless, their use is compromised by high production costs, limited stability,…”
Get full text
Journal Article -
15
A novel PSMA/GCPII‐deficient mouse model shows enlarged seminal vesicles upon aging
Published in The Prostate (01-02-2019)“…Background Prostate‐specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II (GCPII), is an important diagnostic and therapeutic target in…”
Get full text
Journal Article -
16
Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII
Published in FEBS open bio (01-09-2017)“…Glutamate carboxypeptidase II (GCPII), also known as prostate‐specific membrane antigen (PSMA) or folate hydrolase, is a metallopeptidase expressed…”
Get full text
Journal Article -
17
Glutamate carboxypeptidase II does not process amyloid‐β peptide
Published in The FASEB journal (01-07-2013)“…The accumulation of amyloid‐β (Aβ) peptide is thought to be a major causative mechanism of Alzheimer's disease. Aβ accumulation could be caused by dysregulated…”
Get full text
Journal Article -
18
iBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties
Published in Angewandte Chemie (12-02-2016)“…Antibodies are indispensable tools for biomedicine and anticancer therapy. Nevertheless, their use is compromised by high production costs, limited stability,…”
Get full text
Journal Article -
19
Polymers as tools for studying the internalization of membrane protein glutamate carboxypeptidase II
Published in Journal of controlled release (10-08-2017)Get full text
Journal Article